| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | chromosome organization | CENPN ATR CENPF CEP192 P3H4 HELB CDC45 RIF1 PARP4 RESF1 BRCA2 CCT5 CCT8 TOP3B | 5.59e-06 | 686 | 100 | 14 | GO:0051276 |
| GeneOntologyBiologicalProcess | protein localization to chromosome, telomeric region | 1.69e-05 | 32 | 100 | 4 | GO:0070198 | |
| GeneOntologyBiologicalProcess | venous blood vessel morphogenesis | 3.05e-05 | 13 | 100 | 3 | GO:0048845 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | PRAMEF10 PDGFB AKAP3 PRAMEF17 NLRP9 CCM2 HEG1 BRCA2 CCNB2 CHRD NCOA1 NLRP5 | 3.14e-05 | 596 | 100 | 12 | GO:0001701 |
| GeneOntologyBiologicalProcess | establishment of protein localization to telomere | 8.56e-05 | 18 | 100 | 3 | GO:0070200 | |
| GeneOntologyBiologicalProcess | venous blood vessel development | 1.19e-04 | 20 | 100 | 3 | GO:0060841 | |
| GeneOntologyBiologicalProcess | telomere maintenance | 1.69e-04 | 168 | 100 | 6 | GO:0000723 | |
| Domain | DAPIN | 5.91e-06 | 22 | 103 | 4 | PS50824 | |
| Domain | PYRIN | 5.91e-06 | 22 | 103 | 4 | SM01289 | |
| Domain | PYRIN | 5.91e-06 | 22 | 103 | 4 | PF02758 | |
| Domain | DAPIN | 5.91e-06 | 22 | 103 | 4 | IPR004020 | |
| Domain | NACHT | 7.13e-06 | 23 | 103 | 4 | PS50837 | |
| Domain | NACHT_NTPase | 7.13e-06 | 23 | 103 | 4 | IPR007111 | |
| Domain | - | NLRP11 PRAMEF10 NLRP7 PRAMEF17 FBXL4 NLRP9 PHLPP1 CD180 NLRP5 | 7.13e-05 | 321 | 103 | 9 | 3.80.10.10 |
| Domain | L_dom-like | NLRP11 PRAMEF10 NLRP7 PRAMEF17 FBXL4 NLRP9 PHLPP1 CD180 NLRP5 | 8.40e-05 | 328 | 103 | 9 | IPR032675 |
| Domain | LRR_6 | 2.40e-04 | 55 | 103 | 4 | PF13516 | |
| Domain | ARM-type_fold | 5.78e-04 | 339 | 103 | 8 | IPR016024 | |
| Domain | - | 1.01e-03 | 207 | 103 | 6 | 1.25.40.10 | |
| Domain | Chaperonin_TCP-1_CS | 1.06e-03 | 9 | 103 | 2 | IPR002194 | |
| Domain | Beta-tubulin_BS | 1.32e-03 | 10 | 103 | 2 | IPR013838 | |
| Domain | TCP1_1 | 1.32e-03 | 10 | 103 | 2 | PS00750 | |
| Domain | TCP1_2 | 1.32e-03 | 10 | 103 | 2 | PS00751 | |
| Domain | TCP1_3 | 1.32e-03 | 10 | 103 | 2 | PS00995 | |
| Domain | Chaperone_TCP-1 | 1.32e-03 | 10 | 103 | 2 | IPR017998 | |
| Domain | Beta_tubulin | 1.32e-03 | 10 | 103 | 2 | IPR002453 | |
| Domain | - | 1.45e-03 | 222 | 103 | 6 | 1.25.10.10 | |
| Domain | - | 1.60e-03 | 11 | 103 | 2 | 3.30.260.10 | |
| Domain | TCP-1-like_intermed | 1.60e-03 | 11 | 103 | 2 | IPR027410 | |
| Domain | TUBULIN_B_AUTOREG | 1.60e-03 | 11 | 103 | 2 | PS00228 | |
| Domain | - | 1.75e-03 | 93 | 103 | 4 | 1.10.533.10 | |
| Domain | TPR-like_helical_dom | 1.85e-03 | 233 | 103 | 6 | IPR011990 | |
| Domain | DEATH-like_dom | 2.20e-03 | 99 | 103 | 4 | IPR011029 | |
| Domain | TPR_REGION | 2.21e-03 | 165 | 103 | 5 | PS50293 | |
| Domain | TPR | 2.21e-03 | 165 | 103 | 5 | PS50005 | |
| Domain | GROEL-like_equatorial | 2.62e-03 | 14 | 103 | 2 | IPR027413 | |
| Domain | - | 2.62e-03 | 14 | 103 | 2 | 1.10.560.10 | |
| Domain | GroEL-like_apical_dom | 3.02e-03 | 15 | 103 | 2 | IPR027409 | |
| Domain | Cpn60/TCP-1 | 3.02e-03 | 15 | 103 | 2 | IPR002423 | |
| Domain | Cpn60_TCP1 | 3.02e-03 | 15 | 103 | 2 | PF00118 | |
| Domain | - | 3.02e-03 | 15 | 103 | 2 | 3.50.7.10 | |
| Domain | ARM-like | 3.83e-03 | 270 | 103 | 6 | IPR011989 | |
| Domain | Leu-rich_rpt | 3.90e-03 | 271 | 103 | 6 | IPR001611 | |
| Domain | PRAME_family | 4.84e-03 | 19 | 103 | 2 | IPR026271 | |
| Domain | - | 5.36e-03 | 20 | 103 | 2 | 3.30.1330.20 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 9.08e-06 | 26 | 73 | 4 | M9648 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 2.42e-05 | 33 | 73 | 4 | M27297 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 4.93e-05 | 127 | 73 | 6 | M27181 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 5.39e-05 | 129 | 73 | 6 | MM14894 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 8.18e-05 | 202 | 73 | 7 | MM15362 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 8.71e-05 | 204 | 73 | 7 | M4217 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 1.43e-04 | 20 | 73 | 3 | M47890 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 2.04e-04 | 234 | 73 | 7 | MM14898 | |
| Pathway | REACTOME_CELL_CYCLE | RANBP2 CENPN ATR CENPF TUBB2B CEP192 TUBB2A NUP205 CDC45 BRCA2 CCNB2 SYNE2 | 2.14e-04 | 694 | 73 | 12 | M543 |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 2.15e-04 | 236 | 73 | 7 | M27185 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 3.56e-04 | 27 | 73 | 3 | MM15549 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 4.20e-04 | 68 | 73 | 4 | MM14921 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WEE1_CELL_CYCLE_G2_M | 5.46e-04 | 7 | 73 | 2 | M47574 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 6.41e-04 | 76 | 73 | 4 | M27215 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 7.86e-04 | 140 | 73 | 5 | M27550 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 8.12e-04 | 141 | 73 | 5 | MM15266 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 8.41e-04 | 36 | 73 | 3 | M27245 | |
| Pathway | REACTOME_M_PHASE | 8.50e-04 | 387 | 73 | 8 | MM15364 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | 8.52e-04 | 297 | 73 | 7 | M27050 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M | 9.30e-04 | 9 | 73 | 2 | M47586 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.15e-03 | 40 | 73 | 3 | MM14945 | |
| Pathway | PID_FOXM1_PATHWAY | 1.15e-03 | 40 | 73 | 3 | M176 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M | 1.16e-03 | 10 | 73 | 2 | M47572 | |
| Pathway | REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC | 1.16e-03 | 10 | 73 | 2 | M27299 | |
| Pathway | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | 1.16e-03 | 10 | 73 | 2 | MM15004 | |
| Pathway | REACTOME_M_PHASE | 1.37e-03 | 417 | 73 | 8 | M27662 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_CDC25_CELL_CYCLE_G2M | 1.41e-03 | 11 | 73 | 2 | M47573 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.42e-03 | 43 | 73 | 3 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.62e-03 | 45 | 73 | 3 | M47670 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 1.66e-03 | 98 | 73 | 4 | M776 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.72e-03 | 46 | 73 | 3 | M27828 | |
| Pubmed | 2.34e-10 | 28 | 105 | 6 | 25089626 | ||
| Pubmed | 7.67e-08 | 14 | 105 | 4 | 20403135 | ||
| Pubmed | 7.67e-08 | 14 | 105 | 4 | 12563287 | ||
| Pubmed | RANBP2 CENPF ECPAS ATAD2 VIRMA NUP205 TTLL12 RIF1 URB1 CCT5 SYNE2 HELZ2 | 6.91e-07 | 653 | 105 | 12 | 22586326 | |
| Pubmed | Structural, expression, and evolutionary analysis of mouse CIAS1. | 9.28e-07 | 7 | 105 | 3 | 15302403 | |
| Pubmed | Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice. | 2.02e-06 | 30 | 105 | 4 | 38786026 | |
| Pubmed | 4.33e-06 | 11 | 105 | 3 | 11532003 | ||
| Pubmed | Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase. | 5.95e-06 | 39 | 105 | 4 | 25944111 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 30621030 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25933514 | ||
| Pubmed | Cerebral cavernous malformations arise independent of the heart of glass receptor. | 9.03e-06 | 2 | 105 | 2 | 24643410 | |
| Pubmed | Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility. | 9.03e-06 | 2 | 105 | 2 | 27690720 | |
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 1.06e-05 | 95 | 105 | 5 | 27129302 | |
| Pubmed | PPP1R21 ECPAS TRIM24 TUBB2A NUP205 BRCA2 CCT5 TNFRSF8 SYNE2 IRAG2 WWC1 | 1.82e-05 | 754 | 105 | 11 | 35906200 | |
| Pubmed | 2.21e-05 | 277 | 105 | 7 | 30745168 | ||
| Pubmed | PEX14 is required for microtubule-based peroxisome motility in human cells. | 2.21e-05 | 54 | 105 | 4 | 21525035 | |
| Pubmed | 2.31e-05 | 187 | 105 | 6 | 26460568 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 24672057 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 15474461 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 33583041 | ||
| Pubmed | Exogenous transferrin is taken up and localized by the neurulation-stage mouse embryo in vitro. | 2.70e-05 | 3 | 105 | 2 | 1397688 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 33574497 | ||
| Pubmed | Role of Nesprin-2 and RanBP2 in BICD2-associated brain developmental disorders. | 2.70e-05 | 3 | 105 | 2 | 36930595 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 6688039 | ||
| Pubmed | Structural basis of the junctional anchorage of the cerebral cavernous malformations complex. | 2.70e-05 | 3 | 105 | 2 | 23007647 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 35017578 | ||
| Pubmed | 2.94e-05 | 20 | 105 | 3 | 26694250 | ||
| Pubmed | ETAA1 acts at stalled replication forks to maintain genome integrity. | 3.42e-05 | 21 | 105 | 3 | 27723720 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 3.71e-05 | 123 | 105 | 5 | 26912792 | |
| Pubmed | 3.95e-05 | 22 | 105 | 3 | 31729367 | ||
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | 4.54e-05 | 424 | 105 | 8 | 21731673 | |
| Pubmed | Involvement of Nlrp9a/b/c in mouse preimplantation development. | 5.40e-05 | 4 | 105 | 2 | 32413845 | |
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 20513533 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 1685890 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 28273463 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 30734931 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 10935545 | ||
| Pubmed | Regulation of Serine-Threonine Kinase Akt Activation by NAD+-Dependent Deacetylase SIRT7. | 5.40e-05 | 4 | 105 | 2 | 28147277 | |
| Pubmed | ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status. | 5.40e-05 | 4 | 105 | 2 | 23548269 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | PPP1R21 PRAMEF10 OBSCN PRAMEF17 TUBB2A NUP205 CDC45 ANKAR CCT8 | 5.50e-05 | 564 | 105 | 9 | 21565611 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RANBP2 DHX40 TUBB2B CEP192 ECPAS NUP205 BRCA2 CCT5 CCNB2 CCT8 AP4B1 | 5.56e-05 | 853 | 105 | 11 | 28718761 |
| Pubmed | RANBP2 ATR KDM5C ECPAS VIRMA NUP205 CDC45 DFFA RIF1 CCT5 CCT8 FKBP5 | 5.73e-05 | 1014 | 105 | 12 | 32416067 | |
| Pubmed | 5.86e-05 | 25 | 105 | 3 | 37451217 | ||
| Pubmed | 6.01e-05 | 222 | 105 | 6 | 37071664 | ||
| Pubmed | 6.19e-05 | 326 | 105 | 7 | 17015433 | ||
| Pubmed | Interactome of the negative regulator of nuclear import BRCA1-binding protein 2. | 6.61e-05 | 26 | 105 | 3 | 25820252 | |
| Pubmed | 6.63e-05 | 226 | 105 | 6 | 31452512 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 7.56e-05 | 588 | 105 | 9 | 38580884 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 8.03e-05 | 736 | 105 | 10 | 29676528 | |
| Pubmed | Mitochondria-cytoskeleton interaction: distribution of β-tubulins in cardiomyocytes and HL-1 cells. | 8.97e-05 | 5 | 105 | 2 | 21296049 | |
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 18642075 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 38244928 | ||
| Pubmed | LINC complexes form by binding of three KASH peptides to domain interfaces of trimeric SUN proteins. | 8.97e-05 | 5 | 105 | 2 | 22632968 | |
| Pubmed | A-kinase anchoring protein 4 binding proteins in the fibrous sheath of the sperm flagellum. | 8.97e-05 | 5 | 105 | 2 | 12606363 | |
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 17962088 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RANBP2 ATR DNAH10 CENPF ECPAS ATAD2 NUP205 CDC45 TTLL12 DFFA RIF1 URB1 CCT5 CCT8 | 9.93e-05 | 1425 | 105 | 14 | 30948266 |
| Pubmed | 1.01e-04 | 152 | 105 | 5 | 38360978 | ||
| Pubmed | PRAMEF33 PRAMEF10 CENPN TAGAP OBSCN CEP192 PRAMEF17 IRGQ KLHL5 URB1 RESF1 AOPEP | 1.08e-04 | 1084 | 105 | 12 | 11544199 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 1.09e-04 | 357 | 105 | 7 | 37059091 | |
| Pubmed | 1.15e-04 | 250 | 105 | 6 | 33536335 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.21e-04 | 774 | 105 | 10 | 15302935 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 1.33e-04 | 495 | 105 | 8 | 27705803 | |
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 12387869 | ||
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 10748209 | ||
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 9259327 | ||
| Pubmed | 1.53e-04 | 166 | 105 | 5 | 34687317 | ||
| Pubmed | 1.63e-04 | 35 | 105 | 3 | 19389355 | ||
| Pubmed | 1.78e-04 | 36 | 105 | 3 | 23658844 | ||
| Pubmed | MAPKAP1 CENPN KDM5C ATAD2 VIRMA DIPK2A FBXL4 NUP205 CDC45 CCT5 TRIM56 PHLPP1 NCOA1 | 1.84e-04 | 1327 | 105 | 13 | 32694731 | |
| Pubmed | Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint. | 1.88e-04 | 7 | 105 | 2 | 20818375 | |
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 1656220 | ||
| Pubmed | The interaction of Epac1 and Ran promotes Rap1 activation at the nuclear envelope. | 1.88e-04 | 7 | 105 | 2 | 20547757 | |
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 27010057 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.12e-04 | 398 | 105 | 7 | 35016035 | |
| Pubmed | SETDB1 Links the Meiotic DNA Damage Response to Sex Chromosome Silencing in Mice. | 2.50e-04 | 8 | 105 | 2 | 30393076 | |
| Pubmed | M phase-specific association of human topoisomerase IIIbeta with chromosomes. | 2.50e-04 | 8 | 105 | 2 | 11549288 | |
| Pubmed | Human TRiC complex purified from HeLa cells contains all eight CCT subunits and is active in vitro. | 2.50e-04 | 8 | 105 | 2 | 23011926 | |
| Pubmed | 2.50e-04 | 8 | 105 | 2 | 12019269 | ||
| Pubmed | 2.50e-04 | 8 | 105 | 2 | 22133715 | ||
| Pubmed | Mutations in the β-tubulin gene TUBB5 cause microcephaly with structural brain abnormalities. | 2.50e-04 | 8 | 105 | 2 | 23246003 | |
| Pubmed | 2.50e-04 | 8 | 105 | 2 | 9774463 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | RANBP2 KDM5C ECPAS TRIM24 TUBB2A P3H4 MEIS1 NUP205 RIF1 TOP3B | 2.74e-04 | 857 | 105 | 10 | 25609649 |
| Pubmed | FBXL13 directs the proteolysis of CEP192 to regulate centrosome homeostasis and cell migration. | 2.82e-04 | 42 | 105 | 3 | 29348145 | |
| Pubmed | 2.85e-04 | 418 | 105 | 7 | 34709266 | ||
| Pubmed | 3.21e-04 | 9 | 105 | 2 | 7601114 | ||
| Pubmed | 3.21e-04 | 9 | 105 | 2 | 12404116 | ||
| Pubmed | 3.21e-04 | 9 | 105 | 2 | 20605778 | ||
| Pubmed | Molecular markers of neuronal progenitors in the embryonic cerebellar anlage. | 3.21e-04 | 9 | 105 | 2 | 17122047 | |
| Pubmed | 3.21e-04 | 9 | 105 | 2 | 7828721 | ||
| Pubmed | 3.21e-04 | 9 | 105 | 2 | 10336634 | ||
| Pubmed | The CCT/TRiC chaperonin is required for maturation of sphingosine kinase 1. | 3.21e-04 | 9 | 105 | 2 | 18775504 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 3.38e-04 | 197 | 105 | 5 | 20811636 | |
| Pubmed | 3.46e-04 | 45 | 105 | 3 | 30619335 | ||
| Pubmed | 3.73e-04 | 437 | 105 | 7 | 20562859 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.79e-04 | 202 | 105 | 5 | 33005030 | |
| Pubmed | 4.00e-04 | 10 | 105 | 2 | 22898778 | ||
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 4.00e-04 | 10 | 105 | 2 | 30595551 | |
| Pubmed | Expression of cellular oncogenes during embryonic and fetal development of the mouse. | 4.00e-04 | 10 | 105 | 2 | 6594688 | |
| Pubmed | Postnatal refinement of auditory hair cell planar polarity deficits occurs in the absence of Vangl2. | 4.00e-04 | 10 | 105 | 2 | 23986237 | |
| Pubmed | 4.00e-04 | 10 | 105 | 2 | 9420335 | ||
| Interaction | MAPK6 interactions | MAPKAP1 DHX40 ECPAS TF TUBB2A RIF1 URB1 BRCA2 CCT5 CCT8 WWC1 | 2.12e-05 | 474 | 99 | 11 | int:MAPK6 |
| Interaction | EML6 interactions | 2.45e-05 | 12 | 99 | 3 | int:EML6 | |
| Interaction | HOXB2 interactions | 2.86e-05 | 36 | 99 | 4 | int:HOXB2 | |
| Interaction | HEG1 interactions | 3.17e-05 | 13 | 99 | 3 | int:HEG1 | |
| Interaction | KIAA0513 interactions | 3.17e-05 | 13 | 99 | 3 | int:KIAA0513 | |
| Interaction | SOX7 interactions | 5.23e-05 | 82 | 99 | 5 | int:SOX7 | |
| Interaction | PSMD14 interactions | DNAH10 FSIP1 TUBB2B ECPAS VIRMA TUBB2A NLRP9 CCT5 SYNE2 CCT8 SVOP | 5.57e-05 | 527 | 99 | 11 | int:PSMD14 |
| Interaction | NUP43 interactions | RANBP2 KDM5C ATAD2 VIRMA ZNF518A HELB RIF1 RESF1 BRCA2 CCT5 SYNE2 CCT8 | 5.62e-05 | 625 | 99 | 12 | int:NUP43 |
| Interaction | FAM86B2 interactions | 6.15e-05 | 16 | 99 | 3 | int:FAM86B2 | |
| Interaction | SIRT7 interactions | RANBP2 ATR CENPF ECPAS ATAD2 VIRMA NUP205 TTLL12 RIF1 URB1 CCT5 SYNE2 HELZ2 | 7.07e-05 | 744 | 99 | 13 | int:SIRT7 |
| Interaction | NR3C2 interactions | 7.63e-05 | 46 | 99 | 4 | int:NR3C2 | |
| Interaction | TUBB3 interactions | 7.80e-05 | 453 | 99 | 10 | int:TUBB3 | |
| Interaction | TSSK6 interactions | 8.31e-05 | 47 | 99 | 4 | int:TSSK6 | |
| Interaction | STK32A interactions | 8.89e-05 | 18 | 99 | 3 | int:STK32A | |
| Interaction | TEP1 interactions | 9.03e-05 | 48 | 99 | 4 | int:TEP1 | |
| Interaction | CLSPN interactions | 9.06e-05 | 92 | 99 | 5 | int:CLSPN | |
| Interaction | SLX4 interactions | RANBP2 DHX40 TUBB2B TRIM24 VIRMA TUBB2A ZNF518A RESF1 BRCA2 CCT5 CCT8 | 1.15e-04 | 572 | 99 | 11 | int:SLX4 |
| GeneFamily | NLR family | 2.45e-06 | 25 | 70 | 4 | 666 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 2.45e-06 | 25 | 70 | 4 | 994 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.03e-03 | 115 | 70 | 4 | 769 | |
| GeneFamily | Chaperonins | 1.50e-03 | 15 | 70 | 2 | 587 | |
| GeneFamily | PRAME family | 3.86e-03 | 24 | 70 | 2 | 686 | |
| GeneFamily | Tubulins | 4.52e-03 | 26 | 70 | 2 | 778 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | RANBP2 CENPN ATR CENPF ADNP2 CEP192 ATAD2 TRIM24 NUP205 CDC45 RIF1 KLHL5 BRCA2 CCNB2 CCT8 TRMT61B DEPDC1B FKBP5 | 8.70e-06 | 1407 | 103 | 18 | M14427 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 9.35e-06 | 187 | 103 | 7 | M2984 | |
| Coexpression | HOXA9_DN.V1_DN | 1.04e-05 | 190 | 103 | 7 | M2848 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM | 1.11e-05 | 354 | 103 | 9 | M39061 | |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_UP | 1.36e-05 | 198 | 103 | 7 | M3171 | |
| Coexpression | GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP | 1.40e-05 | 199 | 103 | 7 | M9759 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP | 1.45e-05 | 200 | 103 | 7 | M5041 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | CENPN CENPF ATAD2 TRIM24 CDC45 RIF1 BRCA2 CCNB2 SYNE2 DEPDC1B | 1.92e-05 | 478 | 103 | 10 | M45785 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL | 2.49e-05 | 300 | 103 | 8 | M45675 | |
| Coexpression | FISCHER_DREAM_TARGETS | CENPN CENPF CEP192 ATAD2 ZNF518A NUP205 CDC45 RIF1 BRCA2 CCT5 GPR137C CCNB2 DEPDC1B FKBP5 | 2.62e-05 | 969 | 103 | 14 | M149 |
| Coexpression | WHITFIELD_CELL_CYCLE_LITERATURE | 2.71e-05 | 44 | 103 | 4 | M2066 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 3.46e-05 | 155 | 103 | 6 | M39041 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | 4.11e-05 | 322 | 103 | 8 | M39060 | |
| Coexpression | WINNEPENNINCKX_MELANOMA_METASTASIS_UP | 4.43e-05 | 162 | 103 | 6 | M6387 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | 7.22e-05 | 450 | 103 | 9 | M45747 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | CENPN CENPF CEP192 ATAD2 TUBB2A NUP205 CDC45 RIF1 BRCA2 CCNB2 SYNE2 DEPDC1B FKBP5 | 8.02e-05 | 939 | 103 | 13 | M45768 |
| Coexpression | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 | 8.26e-05 | 458 | 103 | 9 | M8520 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | CENPN CENPF CEP192 ATAD2 TRIM24 CDC45 RIF1 BRCA2 CCNB2 SYNE2 DEPDC1B | 9.08e-05 | 694 | 103 | 11 | M45767 |
| Coexpression | WHITEFORD_PEDIATRIC_CANCER_MARKERS | 1.00e-04 | 117 | 103 | 5 | M7854 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | CENPN TUBB2B MEIS1 IFNA6 DIPK2A RIF1 IRAG2 CD180 DCUN1D3 TOP3B | 1.03e-04 | 584 | 103 | 10 | MM1080 |
| Coexpression | HU_FETAL_RETINA_AMACRINE | 1.19e-04 | 64 | 103 | 4 | M39261 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RANBP2 ATR CENPF RHOBTB3 TRIM24 RIF1 HEG1 BRCA2 SYNE2 PHLPP1 NCOA1 WWC1 | 1.37e-04 | 856 | 103 | 12 | M4500 |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN | 1.38e-04 | 199 | 103 | 6 | M4571 | |
| Coexpression | GSE3982_DC_VS_TH2_DN | 1.38e-04 | 199 | 103 | 6 | M5486 | |
| Coexpression | GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP | 1.38e-04 | 199 | 103 | 6 | M6198 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 1.42e-04 | 200 | 103 | 6 | M3580 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | 1.51e-04 | 290 | 103 | 7 | M45736 | |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_NK_T_CELL | 1.59e-04 | 129 | 103 | 5 | M41687 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.86e-04 | 300 | 103 | 7 | M8702 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | 1.86e-04 | 300 | 103 | 7 | M39059 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 1.91e-04 | 402 | 103 | 8 | MM454 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | ATR CENPF ADNP2 TRIM24 NUP205 CDC45 RIF1 BRCA2 CCT5 CCNB2 CCT8 | 2.03e-04 | 761 | 103 | 11 | M11961 |
| Coexpression | ODONNELL_TFRC_TARGETS_DN | 2.25e-04 | 139 | 103 | 5 | M6451 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | 2.33e-04 | 526 | 103 | 9 | M2520 | |
| Coexpression | ZHONG_PFC_MAJOR_TYPES_NPCS | 2.49e-04 | 142 | 103 | 5 | M39078 | |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 2.69e-04 | 32 | 103 | 3 | MM657 | |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP | 2.74e-04 | 145 | 103 | 5 | M3045 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_TIP_CELL | 2.74e-04 | 145 | 103 | 5 | M45693 | |
| Coexpression | PATIL_LIVER_CANCER | CENPF RHOBTB3 CEP192 ATAD2 TRIM24 NUP205 CDC45 CCT5 AFP DEPDC1B | 2.76e-04 | 660 | 103 | 10 | M1195 |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 2.82e-04 | 426 | 103 | 8 | M9516 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | 2.92e-04 | 323 | 103 | 7 | M2156 | |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 2.95e-04 | 33 | 103 | 3 | M7409 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_DN | 3.15e-04 | 232 | 103 | 6 | MM1019 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_UP | 3.51e-04 | 153 | 103 | 5 | M18058 | |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING | 3.53e-04 | 237 | 103 | 6 | M7068 | |
| Coexpression | SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP | 3.61e-04 | 154 | 103 | 5 | M3766 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | 4.03e-04 | 567 | 103 | 9 | M45692 | |
| Coexpression | SANSOM_APC_TARGETS | 4.21e-04 | 245 | 103 | 6 | MM735 | |
| Coexpression | WEBER_METHYLATED_LCP_IN_SPERM_DN | 4.22e-04 | 8 | 103 | 2 | M4762 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | 4.63e-04 | 578 | 103 | 9 | M2368 | |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | CENPN CENPF ATAD2 TUBB2A NUP205 CDC45 RIF1 BRCA2 CCNB2 DEPDC1B FKBP5 | 2.61e-06 | 417 | 95 | 11 | GSM399403_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | ATR RHOBTB3 ECPAS TRIM24 ZNF518A LHX9 RIF1 HEG1 RESF1 BRCA2 GPR137C AFP SYNE2 USP40 | 8.87e-06 | 776 | 95 | 14 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.08e-05 | 311 | 95 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | CENPN CENPF TUBB2B ATAD2 TUBB2A CDC45 BRCA2 CCNB2 DEPDC1B FKBP5 | 1.17e-05 | 398 | 95 | 10 | GSM399397_500 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | CENPN CENPF ATAD2 NUP205 CDC45 BRCA2 CCNB2 IRAG2 CD180 DEPDC1B | 1.48e-05 | 409 | 95 | 10 | GSM399452_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.85e-05 | 333 | 95 | 9 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | RANBP2 CENPF EML6 CEP192 ECPAS TRIM24 ZNF518A RIF1 BRCA2 SH3RF3 | 4.74e-05 | 469 | 95 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | 5.40e-05 | 382 | 95 | 9 | gudmap_developingGonad_e14.5_ ovary_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500 | 5.97e-05 | 387 | 95 | 9 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | 6.09e-05 | 388 | 95 | 9 | GSM538352_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | RANBP2 DNAH10 CENPF TUBB2B RIF1 BRCA2 GPR137C SYNE2 PHLPP1 WWC1 | 7.19e-05 | 493 | 95 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | 7.26e-05 | 397 | 95 | 9 | GSM791143_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | CENPN ATR CENPF CEP192 ATAD2 ZNF518A HELB NUP205 CDC45 RIF1 URB1 BRCA2 CCNB2 | 7.42e-05 | 822 | 95 | 13 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 8.30e-05 | 232 | 95 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 9.28e-05 | 410 | 95 | 9 | GSM538387_500 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | 1.07e-04 | 418 | 95 | 9 | GSM538350_500 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | 1.09e-04 | 419 | 95 | 9 | GSM538348_500 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | 1.15e-04 | 422 | 95 | 9 | GSM538357_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | RANBP2 CENPF RHOBTB3 EML6 CEP192 ECPAS ATAD2 ZNF518A RIF1 BRCA2 | 1.34e-04 | 532 | 95 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.60e-04 | 258 | 95 | 7 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | MAPKAP1 RANBP2 CENPF TUBB2B RIF1 GPR137C N6AMT1 TRIM56 SYNE2 USP40 NCOA1 | 1.63e-04 | 654 | 95 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | OLAH ATR TRIM24 DIPK2A ZNF518A LHX9 RIF1 HEG1 RESF1 SYNE2 CNPY1 NLRP5 | 1.81e-04 | 778 | 95 | 12 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.93e-04 | 266 | 95 | 7 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.17e-04 | 361 | 95 | 8 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | ATR CENPF DHX40 CEP192 ATAD2 ZNF518A NUP205 RIF1 URB1 BRCA2 CCNB2 CCT8 | 2.62e-04 | 810 | 95 | 12 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | ATR CENPF FSIP1 CEP192 ATAD2 ZNF518A CDC45 RIF1 URB1 BRCA2 CCNB2 USP40 | 2.93e-04 | 820 | 95 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | 3.01e-04 | 379 | 95 | 8 | gudmap_developingGonad_P2_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_200 | 3.06e-04 | 72 | 95 | 4 | gudmap_developingGonad_P2_ovary_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_200 | 3.19e-04 | 132 | 95 | 5 | gudmap_developingGonad_P2_ovary_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | PPP1R21 RANBP2 CENPF TUBB2B VIRMA ZNF518A RIF1 KLHL5 HEG1 BRCA2 GPR137C SYNE2 | 3.30e-04 | 831 | 95 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | 3.46e-04 | 387 | 95 | 8 | gudmap_developingGonad_e16.5_ovary_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | 4.03e-04 | 396 | 95 | 8 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | RANBP2 DNAH10 CENPF TUBB2B RIF1 BRCA2 GPR137C TRIM56 SYNE2 USP40 PHLPP1 SH3RF3 WWC1 | 4.28e-04 | 983 | 95 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ATR CENPF RHOBTB3 CEP192 ATAD2 TRIM24 ZNF518A RIF1 HEG1 RESF1 BRCA2 CCNB2 N6AMT1 SYNE2 CD180 | 4.29e-04 | 1252 | 95 | 15 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | Stem Cells, SC.MPP34F.BM, Lineage- cKit+ Sca-1+ flk2+ CD34+, Bone marrow, avg-2 | 4.38e-04 | 401 | 95 | 8 | GSM791110_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 4.46e-04 | 402 | 95 | 8 | GSM605898_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | 4.76e-04 | 406 | 95 | 8 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 4.99e-04 | 409 | 95 | 8 | gudmap_developingGonad_e12.5_ovary_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th.TCRbko, TCRd+ Vg2+ CD24+, Thymus, avg-3 | 5.24e-04 | 412 | 95 | 8 | GSM605793_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | 6.13e-04 | 422 | 95 | 8 | GSM476658_500 | |
| CoexpressionAtlas | B cells, MLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R-, Bone marrow, avg-2 | 6.13e-04 | 422 | 95 | 8 | GSM791124_500 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | 6.13e-04 | 422 | 95 | 8 | GSM538355_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | CENPF TAGAP TTC39C RHOBTB3 ATAD2 MEIS1 LHX9 BRCA2 SYNE2 USP40 FKBP5 | 6.35e-04 | 768 | 95 | 11 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | CENPN ATR CENPF CEP192 ATAD2 ZNF518A HELB NUP205 CDC45 RIF1 BRCA2 | 7.29e-04 | 781 | 95 | 11 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 8.43e-04 | 795 | 95 | 11 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | ATR CENPF CEP192 ATAD2 ZNF518A HELB NUP205 CDC45 RIF1 URB1 BRCA2 | 8.43e-04 | 795 | 95 | 11 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | CENPF DHX40 RHOBTB3 EML6 TUBB2B CEP192 TRIM24 RIF1 URB1 HEG1 BRCA2 SYNE2 PHLPP1 | 8.65e-04 | 1060 | 95 | 13 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| ToppCell | Dividing_Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 6.86e-09 | 169 | 105 | 8 | bc859a103cad567caf50c3c3882d2d2017807c73 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|normal_Lymph_Node / Location, Cell class and cell subclass | 1.94e-08 | 193 | 105 | 8 | 5ce93860bc60ce6ecfed3a3d985f84e28781eec1 | |
| ToppCell | (4)_B_Hypermutation|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.10e-08 | 195 | 105 | 8 | 54d2acaff6be6b5604591bdbd7d769ac3e74f223 | |
| ToppCell | severe-T/NK_proliferative|severe / disease stage, cell group and cell class | 2.18e-08 | 196 | 105 | 8 | 89f005216770dbb84378f5d1f20ca11b0ce40faa | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.27e-08 | 197 | 105 | 8 | 0b1fa881abbfcc54b322fc27124db3f8947af016 | |
| ToppCell | severe-T/NK_proliferative|World / disease stage, cell group and cell class | 2.27e-08 | 197 | 105 | 8 | 6b7b068b103fd4f6ceda8e01f4dd39eefc3b3633 | |
| ToppCell | proximal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.27e-08 | 197 | 105 | 8 | 0dd9058aa19d1268ebba9a65555870224b5a5978 | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.27e-08 | 197 | 105 | 8 | 9243617b307acf3df40d93c41cd8d4788699a7ea | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.36e-08 | 198 | 105 | 8 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass | 2.36e-08 | 198 | 105 | 8 | 41e4bc7964a4895dd05bc62f0ef632ce9c89e34f | |
| ToppCell | (0)_NK_dividing|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.36e-08 | 198 | 105 | 8 | c5336d9b802393d6fd6f8446ea4bb6befeb97bfd | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.46e-08 | 199 | 105 | 8 | 305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.46e-08 | 199 | 105 | 8 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.46e-08 | 199 | 105 | 8 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-08 | 199 | 105 | 8 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-08 | 199 | 105 | 8 | fba48342066aab41a8bcb20db40a6df0158e1cbe | |
| ToppCell | Dividing_Macrophages|World / lung cells shred on cell class, cell subclass, sample id | 2.46e-08 | 199 | 105 | 8 | 5c755b6876e164dc847ef7c723f850f227cf3a87 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.55e-08 | 200 | 105 | 8 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.55e-08 | 200 | 105 | 8 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.55e-08 | 200 | 105 | 8 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.55e-08 | 200 | 105 | 8 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | (0)_NK_cells-(0)_NK_dividing|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.55e-08 | 200 | 105 | 8 | 1a630bb327070ffcb111ec36bd8fd4be3627ca2a | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 2.55e-08 | 200 | 105 | 8 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-07 | 168 | 105 | 7 | 2082b15fc7935a211f1c61506b305af5501a21ad | |
| ToppCell | droplet-Lung-21m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.97e-07 | 175 | 105 | 7 | 6751ee4b312d7f87275f2c35e5878cfc3be3ebe3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-07 | 175 | 105 | 7 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | Dividing_Macrophages-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.21e-07 | 178 | 105 | 7 | 6557688c6790a5bcc3b9aea5b8789cf9506b3c54 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.39e-07 | 180 | 105 | 7 | 42f48e646fc6e72ad3cce72409ace3a0b64020a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-07 | 180 | 105 | 7 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | 2.77e-07 | 184 | 105 | 7 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-07 | 184 | 105 | 7 | 6b2449ac65a2322aa0479fba0d89828f243aabbe | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-07 | 184 | 105 | 7 | e90622b82fa7f16a1faaf7a4724c958f2d83341d | |
| ToppCell | URO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type | 2.87e-07 | 185 | 105 | 7 | 0ae9c646679c69a553eda670aef0e0495feb0286 | |
| ToppCell | COVID-cycling-|COVID / Condition, Cell_class and T cell subcluster | 2.87e-07 | 185 | 105 | 7 | eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f | |
| ToppCell | COVID-cycling|COVID / Condition, Cell_class and T cell subcluster | 2.87e-07 | 185 | 105 | 7 | 5112f966735fa48f0606adcfd5c0212ad5d3d77a | |
| ToppCell | Dividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.98e-07 | 186 | 105 | 7 | 0067eb78d4c7e32b9563550d9fcaf13445ee6a48 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-Cycling_NK|Liver / Manually curated celltypes from each tissue | 3.20e-07 | 188 | 105 | 7 | 5eb94e652a734c6f15c68a178e9d05f0febcf34c | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type | 3.20e-07 | 188 | 105 | 7 | 6c05797a5d0635d89ffcf4aca52178687129ccb4 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.32e-07 | 189 | 105 | 7 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | Dividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.32e-07 | 189 | 105 | 7 | d4e88a3e50499d683e3db38aee04490146fe30bb | |
| ToppCell | Int-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type | 3.44e-07 | 190 | 105 | 7 | 005967c540418b85311308072a07c684f4296aef | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.44e-07 | 190 | 105 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 3.57e-07 | 191 | 105 | 7 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-07 | 191 | 105 | 7 | d6e158f16a183c9203c057192342e9b83e79bc89 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-07 | 191 | 105 | 7 | 7cb5c6f2cf27f3503d1b313e402a7410dfe6473e | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 3.57e-07 | 191 | 105 | 7 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-07 | 191 | 105 | 7 | b85a0978dc1e8af4f49423f56dcfd52efce09ed1 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Cycling_T|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.83e-07 | 193 | 105 | 7 | 81e6240cffb094b2aa3684fd0889b6497f47c4f0 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.83e-07 | 193 | 105 | 7 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.96e-07 | 194 | 105 | 7 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.96e-07 | 194 | 105 | 7 | 17af04acd54dd6a895a966cbb4422de25dc4f1e6 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 3.96e-07 | 194 | 105 | 7 | a8ae49157ca3f9e8b3f1750a995aee012dc859b6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-07 | 194 | 105 | 7 | 1a2090e997c70433d07f56bf7cb0a50c4151118c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.96e-07 | 194 | 105 | 7 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.96e-07 | 194 | 105 | 7 | 3c385d93c5fe1a7817813c492f79fdb94d887357 | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 3.96e-07 | 194 | 105 | 7 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | Control-Lymphocyte-T_NK-T_NK_proliferative|Control / Disease, Lineage and Cell Type | 3.96e-07 | 194 | 105 | 7 | 844731b7943d1cfca819b7b89e4e62067bfa0230 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.96e-07 | 194 | 105 | 7 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.96e-07 | 194 | 105 | 7 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.96e-07 | 194 | 105 | 7 | 635d0e88f9c542a1d9363066c6cdbc6e44db76c1 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.96e-07 | 194 | 105 | 7 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.96e-07 | 194 | 105 | 7 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.96e-07 | 194 | 105 | 7 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.10e-07 | 195 | 105 | 7 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.10e-07 | 195 | 105 | 7 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | mild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.10e-07 | 195 | 105 | 7 | 9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.10e-07 | 195 | 105 | 7 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.10e-07 | 195 | 105 | 7 | 47a01b8a92eebeb34ac7f70bf1ab4613a326e24f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.24e-07 | 196 | 105 | 7 | 76f581e35967f8f7c85a8556129f6e8042ad11ca | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.24e-07 | 196 | 105 | 7 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | mild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.24e-07 | 196 | 105 | 7 | b1d9866d5dfaefdb8bedaf01a750d97987acb3d1 | |
| ToppCell | Healthy-T/NK_proliferative|Healthy / disease group, cell group and cell class | 4.24e-07 | 196 | 105 | 7 | 91e44aabb2e85dcc77ddae6f7e000118d45d1de6 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 4.24e-07 | 196 | 105 | 7 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.39e-07 | 197 | 105 | 7 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-SEP / Disease, Lineage and Cell Type | 4.39e-07 | 197 | 105 | 7 | 908e91fa16134b61943aea5e8fc0d6fbac8a8c6e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.39e-07 | 197 | 105 | 7 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Healthy-T/NK_proliferative|World / disease group, cell group and cell class | 4.39e-07 | 197 | 105 | 7 | e90be1e7e02f736b6aab14010a912b592d6f1e80 | |
| ToppCell | Healthy/Control-T/NK_proliferative|World / Disease group and Cell class | 4.39e-07 | 197 | 105 | 7 | 4a4d3083938783d6f5b87da02f10e501917da0b4 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class | 4.39e-07 | 197 | 105 | 7 | 718a84e9a8248080f2d964e7c6a3ba183ece9592 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.39e-07 | 197 | 105 | 7 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.39e-07 | 197 | 105 | 7 | 47be19f595135da248469b2e21b8d88f561827b2 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.39e-07 | 197 | 105 | 7 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 4.54e-07 | 198 | 105 | 7 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | (4)_B_cells-(4)_B_Hypermutation|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.54e-07 | 198 | 105 | 7 | 8be724a49b4c911d68c3e82fb75e96722d0eaa03 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 4.54e-07 | 198 | 105 | 7 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass | 4.54e-07 | 198 | 105 | 7 | 21c4762ca8591804cf77a23b64470e60d25c5357 | |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.54e-07 | 198 | 105 | 7 | 4d8591eabb543ed789f963b507a07c560c76a7c9 | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.54e-07 | 198 | 105 | 7 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 4.54e-07 | 198 | 105 | 7 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | (3)_DC_Monocyte_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.54e-07 | 198 | 105 | 7 | e2b89f6d7c0007ccab62495cd543fe0e5513a9a4 | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.54e-07 | 198 | 105 | 7 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.54e-07 | 198 | 105 | 7 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | distal-1-Hematologic-Proliferating_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.54e-07 | 198 | 105 | 7 | df3f5559ecd1f3cd1fd60e39dbad8741309e83a3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.54e-07 | 198 | 105 | 7 | 80b105a7c7d00ea3b5e586831fbb755bd84f9d1a | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.54e-07 | 198 | 105 | 7 | 2b0716e900bce54ad1825d6dcdaf4ebf31f355c4 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class | 4.54e-07 | 198 | 105 | 7 | 48045689d0969ff0a14eee7086b8e19b0d6b6065 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.54e-07 | 198 | 105 | 7 | c73e906d2d12d6eba0e606958be16e63a2292cd0 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-07 | 198 | 105 | 7 | 8bd9be3f57e7a27935c63c913e486872d52600e7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_dorsal_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 4.54e-07 | 198 | 105 | 7 | dada1c19a261c8e1090957cd7e37f2a43a9fe14f | |
| ToppCell | cycling_basal_cell|World / shred by cell class for turbinate | 4.54e-07 | 198 | 105 | 7 | e86c1224f5b0890a50a25257628e90c790aae7cd | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.03e-04 | 50 | 53 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Cell cycle (expression cluster). | 2.79e-04 | 262 | 53 | 7 | MODULE_54 | |
| Disease | Malignant neoplasm of breast | CENPF OBSCN MEIS1 RIF1 NLRP9 BRCA2 CCT5 AFP SYNE2 ANKRD30A DIO3 NCOA1 ZFYVE26 | 6.94e-05 | 1074 | 100 | 13 | C0006142 |
| Disease | Restless Legs Syndrome | 1.13e-04 | 5 | 100 | 2 | C0035258 | |
| Disease | Moderate albuminuria, diabetic nephropathy | 3.14e-04 | 8 | 100 | 2 | EFO_0000401, HP_0012594 | |
| Disease | facial paralysis (implicated_via_orthology) | 5.03e-04 | 10 | 100 | 2 | DOID:13934 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology) | 5.03e-04 | 10 | 100 | 2 | DOID:0090132 (implicated_via_orthology) | |
| Disease | ptosis (implicated_via_orthology) | 5.03e-04 | 10 | 100 | 2 | DOID:0060260 (implicated_via_orthology) | |
| Disease | tubulinopathy (implicated_via_orthology) | 5.03e-04 | 10 | 100 | 2 | DOID:0112227 (implicated_via_orthology) | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology) | 7.34e-04 | 12 | 100 | 2 | DOID:0050997 (implicated_via_orthology) | |
| Disease | serum hepcidin measurement | 1.68e-03 | 18 | 100 | 2 | EFO_0004504 | |
| Disease | Liver carcinoma | 1.72e-03 | 507 | 100 | 7 | C2239176 | |
| Disease | Chronic myeloproliferative disorder | 1.87e-03 | 19 | 100 | 2 | C1292778 | |
| Disease | Mammary Neoplasms, Experimental | 1.94e-03 | 155 | 100 | 4 | C0024668 | |
| Disease | Mammary Carcinoma, Human | 2.09e-03 | 525 | 100 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.09e-03 | 525 | 100 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 2.14e-03 | 527 | 100 | 7 | C1458155 | |
| Disease | Breast Carcinoma | 2.40e-03 | 538 | 100 | 7 | C0678222 | |
| Disease | Seckel syndrome | 2.51e-03 | 22 | 100 | 2 | C0265202 | |
| Disease | breast cancer (implicated_via_orthology) | 3.24e-03 | 25 | 100 | 2 | DOID:1612 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IDLCLKESTLDECLS | 151 | A0A0G2JMD5 | |
| SESLCETVSQKDVCL | 806 | Q9BXX3 | |
| DLALLAINTLCKDCS | 81 | Q9Y6B7 | |
| ECLECESEALRLESK | 331 | Q8IYW2 | |
| DCFCASRKLDAVAIE | 551 | A6QL63 | |
| SRCILCSKDEVDLDE | 361 | Q8WUY9 | |
| DFLLVLDCCDLSVLK | 141 | Q8N6M6 | |
| LDCCDLSVLKVEEVD | 146 | Q8N6M6 | |
| EACCLVILAAESKVA | 191 | Q9BSQ5 | |
| GADIKSICAEAALCA | 636 | Q6PL18 | |
| ASCLEDLRSKACDIL | 36 | O00273 | |
| DIEASDCCSLQLKNL | 381 | Q99467 | |
| CKAISADSIDGICAR | 151 | Q8IWE4 | |
| TVRCLSCKCLVSEEE | 746 | Q6IQ32 | |
| DCSVCLVRNEASATK | 1611 | P49792 | |
| ELAFESAKILCCISC | 911 | Q92621 | |
| LLALIFEKCELATCT | 86 | O00470 | |
| CSLETTVCLLCSKAD | 581 | Q7Z5J8 | |
| AVECCDKALGLDSAN | 336 | Q13451 | |
| IDLCQKESTLDECLS | 151 | Q5VTA0 | |
| CGLKVACVSAAVSDE | 611 | Q8IX03 | |
| MKCDLRASECEEIAS | 726 | P59045 | |
| CVSDDNRLCTLASLK | 101 | P55073 | |
| ADIHEDAKTCLVLCS | 201 | Q8WXJ9 | |
| CTDALTCIKADLFCD | 191 | P98073 | |
| LAEVICKVRCATELD | 146 | Q8N3F9 | |
| ADGLSSECDCRIKVL | 246 | Q86SJ6 | |
| EELLKAIACVVTACS | 1586 | Q5VYK3 | |
| AIACVVTACSAELEK | 1591 | Q5VYK3 | |
| TLEDHLACKCETVAA | 171 | P01127 | |
| CKLALESELTCFAKD | 101 | Q9NQ69 | |
| IDLLCDKIAISLSAC | 81 | Q8NH70 | |
| SAEFTKDIARCLLCA | 291 | Q6IPT4 | |
| ICDISCDKFLDDDIT | 91 | P00709 | |
| DLELVKCHLTAACCE | 1041 | P59047 | |
| DAVKGDCQSALLALC | 326 | O76027 | |
| KDTSICTDLDGVALC | 1186 | Q9ULI3 | |
| FACEILSLIKLTCSD | 176 | Q8NG92 | |
| KCDTKDDSILCFLEV | 1541 | Q9UKK3 | |
| LKSLEEECESSLCTS | 361 | Q6ZMI0 | |
| KEDNIECLLSTACLL | 286 | Q96PQ7 | |
| LFCEILSVLKLACAD | 176 | Q6IF42 | |
| ADCTAELGETVKLAC | 6021 | Q5VST9 | |
| IFSHLVCSCSKDELE | 1036 | Q13535 | |
| LFVASDVDALCACKI | 21 | O75419 | |
| ACLECELTSKDVTLR | 436 | Q8N9C0 | |
| EACKDLELACETIEI | 1571 | P51587 | |
| SKLECLLNECTSLCE | 1051 | P49454 | |
| CQAFSDALLCKIEDI | 106 | O95067 | |
| LESCKDLSLLDVSFC | 581 | Q9UKA2 | |
| DCDKEACLSFSKEIL | 336 | Q8NDZ4 | |
| CEEKRASISDAALLD | 56 | Q96H22 | |
| LADKLCSEKSDLCET | 71 | Q3B7I2 | |
| DTDLIKQCIDECTAR | 56 | O43325 | |
| TSLCLLKDCEEIRDN | 916 | Q8TEP8 | |
| SCLSEEQLKCLLDEC | 401 | Q8NA03 | |
| ASCDLDRNSLCKKEE | 111 | Q12912 | |
| DLQTILCLACAKEDI | 196 | Q6ZMW3 | |
| CSCAASASLKILDVR | 2341 | Q9BYK8 | |
| TCAVIKAASLDCEDL | 496 | Q8IX18 | |
| AEKSAACEALLEEIA | 3076 | Q8IVF4 | |
| SCDLTCFVGSEDIAK | 201 | Q9NV23 | |
| ICALFLKECEVSSDD | 126 | Q8NG08 | |
| SALIAALCDKDVETL | 21 | Q8WZA9 | |
| ATAATCCQLSEDKLL | 456 | P02771 | |
| DTDEECASLILACLF | 101 | A0A1B0GVS7 | |
| VKDALFCSCLSDILR | 331 | O94955 | |
| KECSILLSEVFEICH | 1171 | Q6ZRI0 | |
| LVVLSCKSSCSLDCD | 11 | P05013 | |
| AVEAKCSLACEYLSE | 356 | Q8N4V2 | |
| LASCESEDSICQLIE | 36 | Q8N103 | |
| AATTEELSELLDCLC | 3501 | Q8WXH0 | |
| LVATAEENLCCEELS | 721 | Q5UIP0 | |
| VILDSEKDDIHCCAL | 1161 | Q9HCM1 | |
| RHADIDTSCKDVLSC | 646 | Q15788 | |
| SIDSDLLCACDLAEE | 431 | Q9BPZ7 | |
| NCSCIKEGLITADAE | 546 | Q86UG4 | |
| EISCALAVSQEADKC | 426 | P48643 | |
| VLDVVRKESESCDCL | 116 | Q13885 | |
| ENCRLTEASCKDLAA | 826 | Q8WX94 | |
| DMADTCVTICLAADK | 221 | P21108 | |
| CDAHQCDDAETILLK | 541 | O60287 | |
| AIVVLCKDAASAASD | 2256 | O60287 | |
| CVIIAKSCDASLAEL | 681 | O75969 | |
| KSCDVLQSVLCGADA | 401 | Q9H2X0 | |
| TSDSCKDIAAVLICN | 841 | Q7RTR0 | |
| CCDDIAAALIACKTL | 901 | Q7RTR0 | |
| CSVCEAALLDVDFNK | 771 | O95985 | |
| ETCDKLTCRDCQLLE | 236 | O15164 | |
| CELALSCEKISEVIV | 376 | Q9BVS5 | |
| ECVSAETTEDCIAKI | 386 | P02787 | |
| SCIDTCEKNSVLEVI | 386 | Q8NER1 | |
| ECSVCLERLDTTAKV | 56 | Q8TEJ3 | |
| IADLFAESLQCKVDC | 261 | Q92791 | |
| VLDVVRKESESCDCL | 116 | Q9BVA1 | |
| CTACVTCSRDDLVEK | 81 | P28908 | |
| CTACVSCSRDDLVEK | 256 | P28908 | |
| IDLCLKESTLDECLS | 151 | O60809 | |
| SCVEECTLLHKSERA | 91 | Q6AHZ1 | |
| TFECNICLDTAKDAV | 36 | Q96GF1 | |
| CENLLTVKDCLASIA | 361 | Q14166 | |
| EIKCVDLSCNELSEV | 1106 | O60346 | |
| ACDDLKTTEKLCESE | 86 | Q8N584 | |
| CDECAKAFSRSAILI | 281 | Q96N95 | |
| LVCCSAKNLRDIDEV | 146 | P50990 | |
| LCEEDATLKELLICS | 901 | Q9NVE5 | |
| DLIELSEKCCSDFDL | 1551 | Q69YN4 | |
| DDLSSIKDAVLSCAV | 1441 | Q68DK2 | |
| IKDAVLSCAVACDKE | 1446 | Q68DK2 | |
| LEALSSDFLACKICL | 11 | Q9BRZ2 | |
| KNCLSEAEACVSRAL | 816 | P41229 | |
| EAAACTLETARCNKV | 81 | Q9Y5N5 |